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function. Again this is entirely consistent with the 2:l 
efficacy ratio with no penalty paid in terms of side-effects. 
The recently published meta-analysis is again entirely con- 
sistent with this result. The results of the Donnelly et al. 
study may also have been influenced by the use of the 
budesonide MD1 without a spacer. There is evidence from a 
number of sources that the budesonide MD1 produces low 
lung delivery which may contribute to its lesser systemic 
side-effects. The addition of the final paragraph about 
anti-leukotriene drugs is odd. Leukotriene antagonists 
undoubtedly shows measurable clinical improvements in 
asthma control; however, the evidence from reports of 
active comparator studies is that inhaled steroids below 
doses which cause any peritibation of adrenocortical 
function are more effective. 
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Re: Asthma in the elderly: 
underperceived, underdiagnosed, and 
undertreated; a community survey 
The underdiagnosis of asthma in the elderly (l), even 
among life-long non-smokers, may partly be a consequence 
of the fact that the longer the duration of asthma (or the 
older the patient), the more likely the resemblance to 
chronic obstructive pulmonary disease (COPD), perhaps 
because of stigmata common to both diseases, such as small 
airways involvement. The latter was documented in 12 out 
of 24 asthmatics of mean age 47 years, with symptoms of 
>.5 years duration, in a recent pilot study (2). The under- 
treatment of asthmatics misclassified as having COPD can 
be remedied by implementing identical modules of stepped 
care for the two disorders (3), especially justifiable in view 
of the fact that the beneficial effects of inhaled cortico- 
steroids on exercise capacity and frequency of severe 
relapses extend to patients with proven COPD, even when 
they are predominantly unresponsive to inhaled metered- 
dose beta-adrenergic stimulant bronchodilators (4). 
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